BackIncyte Overview

Incyte Current Cash

Incyte's current cash is $4B.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$3.98B

Peer trimmed avg / median

Loading

Incyte Current Cash History

Loading

Incyte vs. peers: Current Cash Comparison

Loading

Incyte Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Incyte (INCY) FAQ

The latest current cash for INCY is $4B as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Incyte's historical trend and sector peers before judging valuation or financial health.

Over the past year, INCY's current cash moved from $0 to $4B. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Incyte's operating scale or balance-sheet position.

A current cash figure of $4B for INCY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting INCY's current cash ($4B), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Incyte's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.